[Skip to Content]
[Skip to Content Landing]
Comment & Response
August 2016

Proton Pump Inhibitors and Dementia Incidence

Author Affiliations
  • 1Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Neurol. 2016;73(8):1025-1026. doi:10.1001/jamaneurol.2016.1491

To the Editor I read with interest the article by Gomm and colleagues,1 which examined the association between the use of proton pump inhibitors (PPIs) and incident dementia in elderly individuals in a prospective study. The authors adopted time-dependent Cox regression analysis, and the time-dependent covariates were polypharmacy and the comorbidities of depression, diabetes, ischemic heart disease, and stroke. Age and sex were also used as confounding factors. The hazard ratio of PPIs for incident dementia was 1.44 (95% CI, 1.36-1.52), and the authors recommended randomized clinical trials to confirm the causal association.1 I appreciate their conservative opinion and editorial comments seem appropriate in combination with information from past research.2 I have some concerns on their study.

First Page Preview View Large
First page PDF preview
First page PDF preview